dc.creatorRamírez de Arellano, Adrián
dc.creatorPereira Suárez, Ana Laura
dc.creatorRico Fuentes, Cecilia
dc.creatorLópez Pulido, Edgar Iván
dc.creatorVillegas Pineda, Julio César
dc.creatorSierra Diaz, Erick
dc.date2022-07-04T19:10:02Z
dc.date2022-07-04T19:10:02Z
dc.date2022-01
dc.date.accessioned2023-07-21T21:45:33Z
dc.date.available2023-07-21T21:45:33Z
dc.identifierRamírez-de-Arellano A, Pereira-Suárez AL, Rico-Fuentes C, López-Pulido EI, Villegas-Pineda JC, Sierra-Diaz E. Distribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms. Front Endocrinol (Lausanne). 2022 Jan 11;12:811578. doi: 10.3389/fendo.2021.811578. PMID: 35087479; PMCID: PMC8786725.
dc.identifier1664-2392 online
dc.identifier1664-2392 Linking
dc.identifierdoi: 10.3389/fendo.2021.811578.
dc.identifierhttp://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/1372
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7752843
dc.descriptionArtículo
dc.descriptionAbstract Estrogens are hormones that have been extensively presented in many types of cancer such as breast, uterus, colorectal, prostate, and others, due to dynamically integrated signaling cascades that coordinate cellular growth, differentiation, and death which can be potentially new therapeutic targets. Despite the historical use of estrogens in the pathogenesis of prostate cancer (PCa), their biological effect is not well known, nor their role in carcinogenesis or the mechanisms used to carry their therapeutic effects of neoplastic in prostate transformation. The expression and regulation of the estrogen receptors (ERs) ERα, ERβ, and GPER stimulated by agonists and antagonists, and related to prostate cancer cells are herein reviewed. Subsequently, the structures of the ERs and their splice variants, the binding of ligands to ERs, and the effect on PCa are provided. Finally, we also assessed the contribution of molecular simulation which can help us to search and predict potential estrogenic activities.
dc.languageen
dc.publisherMedline
dc.relationFront Endocrinol (Lausanne);2022 Jan 11;12:811578
dc.subjectGPER
dc.subjectandrogen deprivation therapies
dc.subjectcastration - resistant prostate cancer
dc.subjectestrogen receptor
dc.subjectprostate cancer
dc.titleDistribution and Effects of Estrogen Receptors in Prostate Cancer: Associated Molecular Mechanisms
dc.typeArticle


Este ítem pertenece a la siguiente institución